Atai Life Sciences Stock Analysis

ATAI Stock  USD 1.97  0.18  10.06%   
ATAI Life Sciences is undervalued with Real Value of 4.35 and Target Price of 12.32. The main objective of ATAI Life stock analysis is to determine its intrinsic value, which is an estimate of what ATAI Life Sciences is worth, separate from its market price. There are two main types of ATAI Life's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect ATAI Life's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of ATAI Life's stock to identify patterns and trends that may indicate its future price movements.
The ATAI Life stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. ATAI Life is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. ATAI Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ATAI Life's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ATAI Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

ATAI Stock Analysis Notes

About 28.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.03. Some equities with similar Price to Book (P/B) outperform the market in the long run. ATAI Life Sciences recorded a loss per share of 0.43. The entity last dividend was issued on the 27th of August 2018. Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany. Atai Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people. For more info on ATAI Life Sciences please contact ChengYaw Sun at 49 89 2153 9035 or go to https://www.atai.life.

ATAI Life Sciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ATAI Life's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ATAI Life Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
ATAI Life Sciences is way too risky over 90 days horizon
ATAI Life Sciences may become a speculative penny stock
ATAI Life Sciences appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 334 K. Net Loss for the year was (66.94 M) with profit before overhead, payroll, taxes, and interest of 233 K.
ATAI Life Sciences currently holds about 304.06 M in cash with (92.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83.
ATAI Life Sciences has a frail financial position based on the latest SEC disclosures
Latest headline from globenewswire.com: atai Life Sciences Announces Positive Initial Results from Beckley Psytechs Phase 2a Open Label Study of BPL-003 in Treatment Resistant Depression

ATAI Life Sciences Upcoming and Recent Events

Earnings reports are used by ATAI Life to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ATAI Life previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

ATAI Largest EPS Surprises

Earnings surprises can significantly impact ATAI Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-03-24
2022-12-31-0.23-0.28-0.0521 
2023-11-14
2023-09-30-0.2-0.28-0.0840 
2021-08-16
2021-06-300.01-0.37-0.383800 
View All Earnings Estimates

ATAI Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as ATAI Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ATAI Life Sciences backward and forwards among themselves. ATAI Life's institutional investor refers to the entity that pools money to purchase ATAI Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Cresset Asset Management, Llc2023-12-31
311.6 K
Tejara Capital Ltd2023-12-31
290.2 K
Barclays Plc2023-12-31
245.7 K
Goldman Sachs Group Inc2023-12-31
223.3 K
Advisorshares Investments, Llc2023-12-31
195.9 K
Hyperion Capital Advisors Lp2023-12-31
168.4 K
Susquehanna International Group, Llp2023-12-31
148.8 K
Hrt Financial Llc2023-12-31
130.8 K
Qube Research & Technologies2023-12-31
128.5 K
Morgan Stanley - Brokerage Accounts2023-12-31
3.1 M
Blackrock Inc2023-12-31
1.4 M
Note, although ATAI Life's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

ATAI Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 275.58 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ATAI Life's market, we take the total number of its shares issued and multiply it by ATAI Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

ATAI Profitablity

ATAI Life's profitability indicators refer to fundamental financial ratios that showcase ATAI Life's ability to generate income relative to its revenue or operating costs. If, let's say, ATAI Life is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, ATAI Life's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of ATAI Life's profitability requires more research than a typical breakdown of ATAI Life's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2024
Return On Capital Employed(0.58)(0.61)
Return On Assets(0.42)(0.44)
Return On Equity(0.49)(0.51)

Management Efficiency

ATAI Life Sciences has return on total asset (ROA) of (0.2425) % which means that it has lost $0.2425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2529) %, meaning that it created substantial loss on money invested by shareholders. ATAI Life's management efficiency ratios could be used to measure how well ATAI Life manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Capital Employed is estimated to decrease to -0.61. The current Return On Assets is estimated to decrease to -0.44. As of now, ATAI Life's Non Current Assets Total are increasing as compared to previous years. The ATAI Life's current Non Currrent Assets Other is estimated to increase to about 12.8 M, while Total Assets are projected to decrease to under 245.6 M.
Last ReportedProjected for 2024
Price Book Value Ratio 1.83  1.74 
Enterprise Value Multiple(1.91)(1.81)
Price Fair Value 1.83  1.74 
The analysis of ATAI Life's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze ATAI Life's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of ATAI Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
0.965

Technical Drivers

As of the 28th of March, ATAI Life owns the market risk adjusted performance of 0.2205, and Coefficient Of Variation of 964.86. ATAI Life Sciences technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the firm's future prices. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We were able to analyze nineteen technical drivers for ATAI Life, which can be compared to its peers in the sector. Please confirm ATAI Life Sciences jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if ATAI Life Sciences is priced correctly, providing market reflects its prevailing price of 1.97 per share. Please also double-check ATAI Life total risk alpha, which is currently at (0.82) to validate the company can sustain itself in the future.

ATAI Life Sciences Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. ATAI Life middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for ATAI Life Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

ATAI Life Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ATAI Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on ATAI Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ATAI Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

ATAI Life Predictive Daily Indicators

ATAI Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ATAI Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

ATAI Life Forecast Models

ATAI Life's time-series forecasting models are one of many ATAI Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ATAI Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About ATAI Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how ATAI Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ATAI shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ATAI Life. By using and applying ATAI Stock analysis, traders can create a robust methodology for identifying ATAI entry and exit points for their positions.
Last ReportedProjected for 2024
Pretax Profit Margin(667.21)(633.85)
Operating Profit Margin(714.61)(678.88)
Net Loss(697.95)(663.05)
Gross Profit Margin 0.32  0.30 

Current ATAI Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. ATAI analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. ATAI analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
12.32Strong Buy7Odds
ATAI Life Sciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most ATAI analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ATAI stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of ATAI Life Sciences, talking to its executives and customers, or listening to ATAI conference calls.
ATAI Analyst Advice Details

ATAI Stock Analysis Indicators

ATAI Life Sciences stock analysis indicators help investors evaluate how ATAI Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading ATAI Life shares will generate the highest return on investment. By understating and applying ATAI Life stock analysis, traders can identify ATAI Life position entry and exit signals to maximize returns.
Begin Period Cash Flow142.5 M
Long Term Debt14.7 M
Common Stock Shares Outstanding155.7 M
Total Stockholder Equity260.7 M
Tax Provision6.6 M
Quarterly Earnings Growth Y O Y-0.968
Property Plant And Equipment Net928 K
Cash And Short Term Investments273.1 M
Cash190.6 M
Accounts Payable2.4 M
Net Debt-175.5 M
50 Day M A1.8386
Total Current Liabilities19.9 M
Non Current Assets Total18.3 M
Common Stock Total Equity18.6 M
Non Currrent Assets Other10.6 M
Stock Based Compensation37.8 M
When determining whether ATAI Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ATAI Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atai Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atai Life Sciences Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ATAI Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the ATAI Life Sciences information on this page should be used as a complementary analysis to other ATAI Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for ATAI Stock analysis

When running ATAI Life's price analysis, check to measure ATAI Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATAI Life is operating at the current time. Most of ATAI Life's value examination focuses on studying past and present price action to predict the probability of ATAI Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATAI Life's price. Additionally, you may evaluate how the addition of ATAI Life to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is ATAI Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATAI Life. If investors know ATAI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATAI Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.97)
Earnings Share
(0.43)
Revenue Per Share
0.002
Quarterly Revenue Growth
2.625
Return On Assets
(0.24)
The market value of ATAI Life Sciences is measured differently than its book value, which is the value of ATAI that is recorded on the company's balance sheet. Investors also form their own opinion of ATAI Life's value that differs from its market value or its book value, called intrinsic value, which is ATAI Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATAI Life's market value can be influenced by many factors that don't directly affect ATAI Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATAI Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATAI Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATAI Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.